Skip to Content
Merck
CN
  • Clinical results of topography-based customized ablations in highly aberrated eyes and keratoconus/ectasia with cross-linking.

Clinical results of topography-based customized ablations in highly aberrated eyes and keratoconus/ectasia with cross-linking.

Journal of refractive surgery (Thorofare, N.J. : 1995) (2013-03-02)
David T C Lin, Simon Holland, Johnson C H Tan, Gregory Moloney
ABSTRACT

To report results of a series of highly aberrated corneas treated with a topography-guided excimer laser ablation. Retrospective, nonrandomized, consecutive series of eyes treated with topography-guided photorefractive keratectomy (TG-PRK) with the customized topographical neutralization technique (TNT). Cases included postoperative refractive surgery decentered ablations, optical zone enlargement, asymmetrical astigmatism, postoperative radial keratotomy (RK), postoperative keratoplasty, keratoconus combined with collagen cross-linking (CXL), and postoperative LASIK ectasia combined with CXL. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and manifest refraction were analyzed preoperatively and 6 months postoperatively. In decentered ablation cases, 94% of 37 eyes were within 1.00 diopter (D) of the attempted refractive outcome, with 76% within 0.50 D. Mean topographic, central, optical zone of uniform (monodioptric) power increased from 3.5 to 5.2 mm in 25 eyes. Thirty-one eyes treated for asymmetrical astigmatism showed improvement in cylinder from mean 1.31 to 0.52 D. Ten of 11 eyes treated for previous RK astigmatism achieved postoperative UDVA 20/40 or better. Twenty-seven eyes with postoperative keratoplasty astigmatism were treated, with 7 (25.9%) eyes gaining > or = 2 lines and 12 (44.4%) eyes gaining > or = 1 line of CDVA. Of eyes with keratoconus that were treated using TG-PRK with CXL, 42 (58%) eyes had UDVA 20/40 or better, and 66 (92%) eyes had CDVA 20/40 or better. Twelve (71%) of 17 eyes treated for postoperative LASIK ectasia using TG-PRK with CXL had UDVA 20/40 or better. Nine (53%) eyes gained > or = 2 lines of CDVA. Topography-guided laser treatment with custom TNT, combined with CXL in keratoconus and ectasia, is an effective, safe, and increasingly predictable option for highly aberrated corneas.

MATERIALS
Product Number
Brand
Product Description

Riboflavin, European Pharmacopoeia (EP) Reference Standard
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
130 mg
Available to ship on 2025年4月03日
Details...
¥1,681.42
Supelco
Riboflavin, Pharmaceutical Secondary Standard; Certified Reference Material
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
1 g
Available to ship on 2025年4月03日
Details...
¥1,252.02
Sigma-Aldrich
(−)-Riboflavin, meets USP testing specifications
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
25 g
Available to ship on 2025年4月03日
Details...
¥589.74
100 g
Please contact Customer Service for Availability
¥1,381.03
500 g
Please contact Customer Service for Availability
¥4,933.76
1 kg
Please contact Customer Service for Availability
¥8,286.19
Sigma-Aldrich
(−)-Riboflavin, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥98%
Pricing and availability is not currently available.
Sigma-Aldrich
(−)-Riboflavin, from Eremothecium ashbyii, ≥98%
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
5 g
Available to ship on 2025年4月03日
Details...
¥452.19
25 g
Available to ship on 2025年4月03日
Details...
¥508.68
100 g
Available to ship on 2025年4月03日
Details...
¥1,413.08
500 g
Available to ship on 2025年4月03日
Details...
¥4,565.19
¥1,369.56
1 kg
Estimated to ship on 2025年5月08日
Details...
¥8,856.43
Supelco
Riboflavin (B2), analytical standard
Pricing and availability is not currently available.